Endra life sciences inc. (NDRA)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16
Revenue

0

6

351

-

Cost of Goods Sold

0

0

172

-

Revenue

-

-

-

515

Cost of Goods Sold

-

-

-

235

Gross Profit

0

6

178

279

Operating Expenses
Research and development

6,574

4,722

1,931

495

Sales and marketing

412

262

122

34

General and administrative

3,856

3,752

2,751

1,541

Impairment of inventory

0

287

0

-

Total operating expenses

10,843

9,025

4,804

2,071

Operating loss

-10,843

-9,019

-4,626

-1,791

Other Expenses
Amortization of debt discount

2,355

729

-

-

Loss on warrant exercise

-

-

-

5

Other income (expense)

-

-

-

977

Total other expenses

-

-

-

983

Other income (expense)

-106

-48

-750

-

Other income (expense)

-106

-48

-750

-

Total other expenses

-2,462

-777

-

-

Loss from operations before income taxes

-13,305

-9,796

-5,376

-2,775

Provision for income taxes

0

0

0

0

Deemed dividend related to preferred stock

4,219

0

-

-

Net Loss attributable to common stockholders

-17,525

-9,796

-

-

Net loss

-

-

-5,376

-2,775

Net loss per share - basic and diluted

-2.34

-2.17

-1.95

-3.84

Weighted average common shares - basic and diluted

7,499

4,504

2,756

723